Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Infinity Pharmaceuticals Inc INFIQ

Healthcare Biotechnology
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on developing medicines for people with cancer. The Company is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma (PI3K... see more

Recent & Breaking News (GREY:INFIQ)

Julian Adams, Ph.D., of Infinity Pharmaceuticals Named Corporate Chair for The Leukemia & Lymphoma Society's Light the Night Walk

Business Wire September 16, 2013

Infinity Expands Executive Leadership Team, Appointing David A. Roth as Senior Vice President, Clinical Development and Medical Affairs

Business Wire September 4, 2013

Infinity Supports Blood Cancer Awareness Month with Launch of Sparks of Inspiration, a Campaign to Honor People Affected by Blood Cancer

Business Wire September 3, 2013

Infinity to Participate in Three Conferences in September

Business Wire August 27, 2013

Infinity Reports Second Quarter 2013 Financial Results and Provides Company Update

Business Wire August 8, 2013

Infinity Announces the Date of Its Second Quarter 2013 Financial Results Conference Call and Webcast

Business Wire August 1, 2013

Infinity to Present at the 2013 JMP Securities Healthcare Conference

Business Wire July 2, 2013

Breakthrough Research that Help Address Complex Diseases and Offer Diverse Treatments - Research Report on Medivation, Jazz, NPS, Infinity and Halozyme

PR Newswire June 27, 2013

Infinity Reports Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 Across a Broad Range of Blood Cancers at the 12th International Conference on Malignant Lymphoma

Business Wire June 24, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on CBMX, INFI, MKTO and ZN

Accesswire June 19, 2013

Strategy Behind Our Success, We Get in Early: NLY, INFI, GRPN and ITUB

Marketwired June 5, 2013

Infinity to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

Business Wire June 5, 2013

Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in B-Cell and T-Cell Lymphomas at ASCO Annual Meeting and Announces Initiation of Phase 2 Clinical Study in Indolent Non-Hodgkin Lymphoma

Business Wire June 3, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, INFI, ISIS and NVAX

Accesswire June 3, 2013

Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia at ASCO Annual Meeting

Business Wire June 2, 2013

Infinity to Present at the Jefferies 2013 Global Healthcare Conference

Business Wire May 28, 2013

Infinity to Present at Deutsche Bank's 38th Annual Health Care Conference

Business Wire May 22, 2013

The Real Story Behind INFI, ARIA, GT and BTU

Marketwired May 18, 2013

HALO, NTAP, INFI and DRYS added to Nasdaq Active Stock Watch List at EPR

Accesswire May 17, 2013

Free Research Reports on DRYS, INFI, JNJ and SCTY Issued by the Bedford Report

Marketwired May 17, 2013